PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trialFlorian Lordick, J. R. Siewert, Sylvie Lorenzen et al.|The Lancet Oncology|2007Cited by 808
Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to TreatmentHinrich Wieder, Wolfgang Weber, Björn L.D.M. Brücher et al.|Journal of Clinical Oncology|2004Cited by 460
ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)Jens Hoeppner, J. R. Siewert, Ulrich T. Hopt et al.|BMC Cancer|2016Cited by 352